IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q3 2021 Holdings

Filed 2021-11-12 | 12 holdings | $73.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$61.2M3,399,03483.0%
Cue Health Inc.(HLTHQ)COM229790100$11.9M1,006,08916.1%
Kinnate Biopharma Inc.COM49705R105$222.6K9,671,6430.3%
Lyell Immunopharma, Inc.COM55083R104$196.6K13,282,1810.3%
Pharvaris N.V.(PHVS)COMN69605108$57.8K3,261,9260.1%
Quantum-Si Incorporated(QSI)COM CL A74765K105$37.2K4,463,6190.1%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$36.1K1,205,7980.0%
Kura Oncology, Inc.(KURA)COM50127T109$34.7K1,849,9470.0%
Olema Pharmaceuticals, Inc.(OLMA)COM68062P106$9.4K342,0300.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$6.5K1,787,0940.0%
Tempest Therapeutics, Inc.(OVASUSD)COM87978U108$2.8K190,2130.0%
Decibel Therapeutics, Inc.COM24343R106$2.3K297,7110.0%